These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31623966)

  • 21. Risk assessment and outcomes of vasoplegia after cardiac surgery.
    Tsiouris A; Wilson L; Haddadin AS; Yun JJ; Mangi AA
    Gen Thorac Cardiovasc Surg; 2017 Oct; 65(10):557-565. PubMed ID: 28612323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthetic Human Angiotensin II for Postcardiopulmonary Bypass Vasoplegic Shock.
    Wieruszewski PM; Radosevich MA; Kashani KB; Daly RC; Wittwer ED
    J Cardiothorac Vasc Anesth; 2019 Nov; 33(11):3080-3084. PubMed ID: 31060933
    [No Abstract]   [Full Text] [Related]  

  • 23. Use of Hydroxocobalamin (Vitamin B12a) in Patients With Vasopressor Refractory Hypotension After Cardiopulmonary Bypass: A Case Series.
    Armour S; Armour TK; Joppa WR; Maltais S; Nelson JA; Wittwer E
    Anesth Analg; 2019 Jul; 129(1):e1-e4. PubMed ID: 29979199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vasoplegia After Cardiovascular Procedures-Pathophysiology and Targeted Therapy.
    Shaefi S; Mittel A; Klick J; Evans A; Ivascu NS; Gutsche J; Augoustides JGT
    J Cardiothorac Vasc Anesth; 2018 Apr; 32(2):1013-1022. PubMed ID: 29223724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe Vasoplegic Shock During Coronary Artery Bypass Surgery: Therapeutic challenges and Dilemmas in Hemodynamic Rescue.
    Shah R; Wenger RK; Patel PA; Davis S; Ha B; Feinman JW; Patel S; Pulton D; Weiss SJ; Restrepo-Cardenas J; Aljure OD; Vasquez CR; Augoustides JG
    J Cardiothorac Vasc Anesth; 2020 May; 34(5):1341-1347. PubMed ID: 32146101
    [No Abstract]   [Full Text] [Related]  

  • 26. Vasoplegia in cardiac surgery: Know your enemy and attack early.
    Slomovits M; Neuburger PJ; Rong LQ
    J Card Surg; 2021 Sep; 36(9):3031-3033. PubMed ID: 34021630
    [No Abstract]   [Full Text] [Related]  

  • 27. Vitamin D and Postoperative Vasopressor Use in Cardiopulmonary Bypass.
    Javorski MJ; Kerolos MM; Fareed J; Perez-Tamayo RA
    Clin Appl Thromb Hemost; 2018 Nov; 24(8):1322-1326. PubMed ID: 29730947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydroxocobalamin as a Rescue Treatment for Refractory Vasoplegic Syndrome After Prolonged Cardiopulmonary Bypass.
    Burnes ML; Boettcher BT; Woehlck HJ; Zundel MT; Iqbal Z; Pagel PS
    J Cardiothorac Vasc Anesth; 2017 Jun; 31(3):1012-1014. PubMed ID: 27838199
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluating the evidence for angiotensin II for the treatment of vasoplegia in critically ill cardiothoracic surgery patients.
    Chow JH; Wittwer ED; Wieruszewski PM; Khanna AK
    J Thorac Cardiovasc Surg; 2022 Apr; 163(4):1407-1414. PubMed ID: 33875258
    [No Abstract]   [Full Text] [Related]  

  • 30. Letter by Gomes and Evora regarding article, "Early on-cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome".
    Gomes WJ; Evora PR
    Circulation; 2010 Jun; 121(22):e431. PubMed ID: 20530017
    [No Abstract]   [Full Text] [Related]  

  • 31. Hydroxocobalamin for the treatment of cardiac surgery-associated vasoplegia: a case series.
    Shah PR; Reynolds PS; Pal N; Tang D; McCarthy H; Spiess BD
    Can J Anaesth; 2018 May; 65(5):560-568. PubMed ID: 29209927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraoperative vasoplegia: methylene blue to the rescue!
    McCartney SL; Duce L; Ghadimi K
    Curr Opin Anaesthesiol; 2018 Feb; 31(1):43-49. PubMed ID: 29176374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylene Blue for Vasoplegic Syndrome After Cardiac Operation: Early Administration Improves Survival.
    Mehaffey JH; Johnston LE; Hawkins RB; Charles EJ; Yarboro L; Kern JA; Ailawadi G; Kron IL; Ghanta RK
    Ann Thorac Surg; 2017 Jul; 104(1):36-41. PubMed ID: 28551045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac vasoplegia syndrome: pathophysiology, risk factors and treatment.
    Omar S; Zedan A; Nugent K
    Am J Med Sci; 2015 Jan; 349(1):80-8. PubMed ID: 25247756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Reminder of Methylene Blue's Effectiveness in Treating Vasoplegic Syndrome after On-Pump Cardiac Surgery.
    Manghelli J; Brown L; Tadros HB; Munfakh NA
    Tex Heart Inst J; 2015 Oct; 42(5):491-4. PubMed ID: 26504450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A retrospective analysis of terlipressin in bolus for the management of refractory vasoplegic hypotension after cardiac surgery.
    Noto A; Lentini S; Versaci A; Giardina M; Risitano DC; Messina R; David A
    Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):588-92. PubMed ID: 19581293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for vasoplegia after cardiac surgery: a meta-analysis.
    Dayan V; Cal R; Giangrossi F
    Interact Cardiovasc Thorac Surg; 2019 Jun; 28(6):838-844. PubMed ID: 30649312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of high-dose hydroxocobalamin for vasoplegic syndrome.
    Roderique JD; VanDyck K; Holman B; Tang D; Chui B; Spiess BD
    Ann Thorac Surg; 2014 May; 97(5):1785-6. PubMed ID: 24792267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylene blue: potential use of an antique molecule in vasoplegic syndrome during cardiac surgery.
    Lenglet S; Mach F; Montecucco F
    Expert Rev Cardiovasc Ther; 2011 Dec; 9(12):1519-25. PubMed ID: 22103871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitamin B12 for the treatment of vasoplegia in cardiac surgery and liver transplantation: a narrative review of cases and potential biochemical mechanisms.
    Charles FG; Murray LJ; Giordano C; Spiess BD
    Can J Anaesth; 2019 Dec; 66(12):1501-1513. PubMed ID: 31346957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.